Media Coverage

CoLucid Pharmaceuticals raises $7.5 million of planned $9.5

Link: http://biomedreports.com/2011083073296/colucid-pharmaceuticals-raises-$7-5-million-of-planned-$9-5-million.html

Back to List

Lasmiditan

image of lasmiditan structure

Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.

Learn More About Lasmiditan